In adults, the circulating levels of FGF21 increase under adverse lipid profiles, obesity, metabolic syndrome, impaired glucose tolerance, type 2 diabetes mellitus, or atherosclerosis [18], but in children its relationship with metabolic syndrome has not been confirmed [19]. The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.